Characterization of myeloid suppressor cell activity in experimental leishmaniasis
Characterization of myeloid suppressor cell activity in experimental leishmaniasis
批准号:
188763720
负责人:
Professor Dr. Uwe Ritter
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2013-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In experimental leishmaniasis, the clinical course of disease depends on the genetically determined ability of the infected mouse strain to mount a protective T cell-mediated immune response. C57BL/6 mice control parasite replication, whereas BALB/c mice develop a chronic course of disease. Considering these divergent phenotypes, it is most likely that parameters regulating the adaptive immune response against L. major parasites differ in C57BL/6 and BALB/c mice. Recently, myeloid suppressor cells have been described to suppress T cell functions. The most potent suppressive cells are inflammatory CD11b+ monocytes (IMC) that are characterized by the expression of high levels of lymphocyte antigen 6 complex C (Ly-6C), but are negative for Ly-6G. We quantified IMCs at the site of infection and skin-draining lymph nodes (SDLNs) of infected C57BL/6 and BALB/c mice. BALB/c mice showed an increase of IMC at the site of infection and SDLNs, whereas the numbers of IMCs in C57BL/6 SDLNs were not affected. Thus, we propose the hypothesis that IMCs migrate to the site of infection and SDLNs of BALB/c mice to suppress the development of an efficient T cell response. The overall goal of this project is to characterize the different T cell-suppressing mechanisms mediated by IMCs in the experimental model of leishmaniasis.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0139866
发表时间:
2015-10-21
期刊:
PLOS ONE
影响因子:
3.7
作者:
[Schmid, Maximilian, Dufner, Bianca, Ritter, Uwe]
通讯作者:
Ritter, Uwe
Die regulatorische und pathologische Bedeutung von dendritischen Zellen für die T-Zell-vermittelte Immunantwort im experimentellen Modell der Leishmaniose
-
批准号:37660748
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Professor Dr. Uwe Ritter
-
依托单位:
国内基金
海外基金
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
STAT3/IDO途径参与乳腺癌髓系来源抑制细胞(MDSCs)下调T细胞免疫及相关机制探讨
-
批准号:81072159
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:于津浦
-
依托单位: